Vietnam Investment Review on MSN3h
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 for Platinum-resistant Ovarian Cancer
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality ...